Effects of supplementation with pomegranate juice on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials

Phytomedicine

Volumn 23, Issue 11, 2016, Pages 1095-1102

  Sahebkar, Amirhossein ^a,b   Gurban, Camelia ^c   Serban, Alexandru ^d   Andrica, Florina ^e   Serban, Maria Corina ^e,f  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c BABE BOLYAI UNIVERSITY   (Romania)

^d POLITEHNICA UNIVERSITY OF TIMISOARA   (Romania)

^e VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Inflammation; Plasma C reactive protein (CRP); Pomegranate juice; Punica granatum

Indexed keywords

C REACTIVE PROTEIN;

CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; META ANALYSIS; PLASMA; POMEGRANATE; POMEGRANATE JUICE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; DIETARY SUPPLEMENT; FRUIT AND VEGETABLE JUICE; LYTHRACEAE; METABOLISM;

C-REACTIVE PROTEIN; DIETARY SUPPLEMENTS; FRUIT AND VEGETABLE JUICES; HUMANS; PUNICACEAE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84959130722     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2015.12.008     Document Type: Review

References (55)

1. Asgary, S., Keshvari, M., Sahebkar, A., Hashemi, M., Rafieian-Kopaei, M., Clinical investigation of the acute effects of pomegranate juice on blood pressure and endothelial function in hypertensive individuals. ARYA Atheroscler. 9 (2013), 326–331.
2. Asgary, S., Sahebkar, A., Afshani, M.R., Keshvari, M., Haghjooyjavanmard, S., Rafieian-Kopaei, M., Clinical evaluation of blood pressure lowering, endothelial function improving, hypolipidemic and anti-inflammatory effects of pomegranate juice in hypertensive subjects. Phytother. Res.: PTR 28 (2014), 193–199.
3. Aviram, M., Rosenblat, M., Pomegranate protection against cardiovascular diseases. evidence-based complementary and alternative medicine. Evidence-Based Complement. Altern. Med., 2012, 2012, 382763.
4. Babaeian, S., Ebrahimi, M.M., Niafar, M., Sanail, S., The effect of unsweetened pomegranate juice on insulin resistance, high sensitivity c-reactive protein and obesity among type 2 diabetes patients. J. Ardabil Univ. Med. Sci. 13:1 (2013), 7–15.
5. Banach, M., Serban, C., Ursoniu, S., Rysz, J., Muntner, P., Toth, P.P., Jones, S.R., Rizzo, M., Glasser, S.P., Watts, G.F., Statin therapy and plasma coenzyme Q10 concentrations—a systematic review and meta-analysis of placebo-controlled trials. Pharmacol. Res. 99 (2015), 329–336.
6. Banihani, S., Swedan, S., Alguraan, Z., Pomegranate and type 2 diabetes. Nutr. Res. 33 (2013), 341–348.
7. Banihani, S.A., Makahleh, S.M., El-Akawi, Z., Al-Fashtaki, R.A., Khabour, O.F., Gharibeh, M.Y., Saadah, N.A., Al-Hashimi, F.H., Al-Khasieb, N.J., Fresh pomegranate juice ameliorates insulin resistance, enhances beta-cell function, and decreases fasting serum glucose in type 2 diabetic patients. Nutr. Res. 34 (2014), 862–867.
8. Basu, A., Newman, E.D., Bryant, A.L., Lyons, T.J., Betts, N.M., Pomegranate polyphenols lower lipid peroxidation in adults with type 2 diabetes but have no effects in healthy volunteers: a pilot study. J. Nutr. Metab., 2013, 2013, 708381.
9. Basu, A., Penugonda, K., Pomegranate juice: a heart-healthy fruit juice. Nutr. Rev. 67 (2009), 49–56.
10. Bell, C., Hawthorne, S., Ellagic acid, pomegranate and prostate cancer – a mini review. J. Pharm. Pharmacol. 60 (2008), 139–144.
11. Borenstein, M., Hedges, L., Higgins, J., Rothstein, H., Comprehensive Meta-Analysis Version 2. 2005, Biostat Inc., Englewood, NJ, 104.
12. Bouroshaki, M.T., Sadeghnia, H.R., Banihasan, M., Yavari, S., Protective effect of pomegranate seed oil on hexachlorobutadiene-induced nephrotoxicity in rat kidneys. Ren. Fail. 32 (2010), 612–617.
13. Boussetta, T., Raad, H., Lettéron, P., Gougerot-Pocidalo, M.-A., Marie, J.-C., Driss, F., El-Benna, J., Punicic acid a conjugated linolenic acid inhibits TNFα-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats. PLoS One, 4, 2009, e6458.
14. Cerdá, B., Cerón, J.J., Tomás-Barberán, F.A., Espín, J.C., Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J. Agric. Food Chem. 51 (2003), 3493–3501.
15. Cerdá, B., Llorach, R., Cerón, J.J., Espín, J.C., Tomás-Barberán, F.A., Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur. J. Nutr. 42 (2003), 18–28.
16. Chen, B., Tuuli, M.G., Longtine, M.S., Shin, J.S., Lawrence, R., Inder, T., Nelson, D.M., Pomegranate juice and punicalagin attenuate oxidative stress and apoptosis in human placenta and in human placental trophoblasts. Am. J. Physiol.-Endocrinol. Metab. 302 (2012), E1142–E1152.
17. Clarke, R., Hopewell, J.C., Peden, J.F., Erdmann, J., Braund, P., Engert, J.C., Bennett, D., Coin, L., Ashby, D., Tzoulaki, I., Genetic loci influencing c-reactive protein levels and risk of coronary heart disease. JAMA 302 (2009), 37–48.
18. Davidson, M.H., Maki, K.C., Dicklin, M.R., Feinstein, S.B., Witchger, M., Bell, M., McGuire, D.K., Provost, J.-C., Liker, H., Aviram, M., Effects of consumption of pomegranate juice on carotid intima–media thickness in men and women at moderate risk for coronary heart disease. Am. J. Cardiol. 104 (2009), 936–942.
19. Davidson, M.H., Maki, K.C., Dicklin, M.R., Feinstein, S.B., Witchger, M., Bell, M., McGuire, D.K., Provost, J.C., Liker, H., Aviram, M., Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. Am. J. Cardiol. 104 (2009), 936–942.
20. de Nigris, F., Balestrieri, M.L., Williams-Ignarro, S., D'Armiento, F.P., Fiorito, C., Ignarro, L.J., Napoli, C., The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. Nitric Oxide 17 (2007), 50–54.
21. de Nigris, F., Williams-Ignarro, S., Botti, C., Sica, V., Ignarro, L.J., Napoli, C., Pomegranate juice reduces oxidized low-density lipoprotein downregulation of endothelial nitric oxide synthase in human coronary endothelial cells. Nitric Oxide 15 (2006), 259–263.
22. Duval, S., Tweedie, R., Trim and fill: a simple funnel‐plot–based method of testing and adjusting for publication bias in meta‐analysis. Biometrics 56 (2000), 455–463.
23. Ferretti, G., Bacchetti, T., Sahebkar, A., Effect of statin therapy on paraoxonase-1 status: a systematic review and meta-analysis of 25 clinical trials. Prog. Lipid Res 60 (2015), 50–73.
24. Gil, M.I., Tomás-Barberán, F.A., Hess-Pierce, B., Holcroft, D.M., Kader, A.A., Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem. 48 (2000), 4581–4589.
25. Hamoud, S., Hayek, T., Volkova, N., Attias, J., Moscoviz, D., Rosenblat, M., Aviram, M., Pomegranate extract (POMx) decreases the atherogenicity of serum and of human monocyte-derived macrophages (HMDM) in simvastatin-treated hypercholesterolemic patients: a double-blinded, placebo-controlled, randomized, prospective pilot study. Atherosclerosis 232 (2014), 204–210.
26. Higgins, J.P., Green, S., Cochrane Handbook for Systematic Reviews of Interventions. 2008, Wiley Online Library.
27. Ignarro, L.J., Byrns, R.E., Sumi, D., de Nigris, F., Napoli, C., Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide. Nitric oxide 15 (2006), 93–102.
28. Jaganathan, S.K., Vellayappan, M.V., Narasimhan, G., Supriyanto, E., Role of pomegranate and citrus fruit juices in colon cancer prevention. World J. Gastroenterol. 20 (2014), 4618–4625.
29. Jeune, M.A., Kumi-Diaka, J., Brown, J., Anticancer activities of pomegranate extracts and genistein in human breast cancer cells. J. Med. Food 8 (2005), 469–475.
30. Koenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W.L., Pepys, M.B., C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men results from the MONICA (monitoring trends and determinants in cardiovascular disease) augsburg cohort study, 1984 to 1992. Circulation 99 (1999), 237–242.
31. Matthaiou, C.M., Goutzourelas, N., Stagos, D., Sarafoglou, E., Jamurtas, A., Koulocheri, S.D., Haroutounian, S.A., Tsatsakis, A.M., Kouretas, D., Pomegranate juice consumption increases GSH levels and reduces lipid and protein oxidation in human blood. Food Chem. Toxicol. 73 (2014), 1–6.
32. Mazani, M., Fard, A.S., Baghi, A.N., Nemati, A., Mogadam, R.A., Effect of pomegranate juice supplementation on matrix metalloproteinases 2 and 9 following exhaustive exercise in young healthy males. J. Pak. Med. Assoc. 64 (2014), 785–790.
33. Mertens-Talcott, S.U., Jilma-Stohlawetz, P., Rios, J., Hingorani, L., Derendorf, H., Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum L.) polyphenols after ingestion of a standardized extract in healthy human volunteers. J. Agric. Food Chem. 54 (2006), 8956–8961.
34. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 151 (2009), 264–269.
35. Nekooeian, A.A., Eftekhari, M.H., Adibi, S., Rajaeifard, A., Effects of pomegranate seed oil on insulin release in rats with type 2 diabetes. Iran. J. Med. Sci. 39 (2014), 130–135.
36. Nuncio-Jáuregui, N., Calín-Sánchez, Á., Vázquez-Araújo, L., Pérez-López, A.J., Frutos-Fernández, M.J., Carbonell-Barrachina, Á.A., Beverages. Preedy, Victor, (eds.) Processing and Impact on Active Components in Food, 2014, Elsevier, 629–636.
37. Ridker, P.M., Hennekens, C.H., Buring, J.E., Rifai, N., C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 (2000), 836–843.
38. Rivara, M.B., Mehrotra, R., Linke, L., Ruzinski, J., Ikizler, T.A., Himmelfarb, J., A pilot randomized crossover trial assessing the safety and short-term effects of pomegranate supplementation in hemodialysis patients. J. Ren. Nutr. 25:1 (2014), 40–49.
39. Rivara, M.B., Mehrotra, R., Linke, L., Ruzinski, J., Ikizler, T.A., Himmelfarb, J., A pilot randomized crossover trial assessing the safety and short-term effects of pomegranate supplementation in hemodialysis patients. J. Ren. Nutr. 25 (2015), 40–49.
40. Rojanathammanee, L., Puig, K.L., Combs, C.K., Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease. J. Nutr. 143 (2013), 597–605.
41. Sahebkar, A., Does PPARγ2 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis. DNA Cell Biol. 32 (2013), 188–198.
42. Sahebkar, A., Are curcuminoids effective c‐reactive protein‐lowering agents in clinical practice? evidence from a meta‐analysis. Phytother. Res. 28 (2014), 633–642.
43. Seeram, N.P., Lee, R., Heber, D., Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin. Chim. Acta 348 (2004), 63–68.
44. Shema-Didi, L., Sela, S., Ore, L., Shapiro, G., Geron, R., Moshe, G., Kristal, B., One year of pomegranate juice intake decreases oxidative stress, inflammation, and incidence of infections in hemodialysis patients: a randomized placebo-controlled trial. Free Radic. Biol. Med. 53 (2012), 297–304.
45. Sohrab, G., Nasrollahzadeh, J., Zand, H., Amiri, Z., Tohidi, M., Kimiagar, M., Effects of pomegranate juice consumption on inflammatory markers in patients with type 2 diabetes: a randomized, placebo-controlled trial. J. Res. Med. Sci. 19 (2014), 215–220.
46. Sreekumar, S., Sithul, H., Muraleedharan, P., Azeez, J.M., Sreeharshan, S., Pomegranate fruit as a rich source of biologically active compounds. BioMed Res. Int., 2014, 2014, 686921.
47. Stowe, C.B., The effects of pomegranate juice consumption on blood pressure and cardiovascular health. Complement. Ther. Clin. Pract. 17 (2011), 113–115.
48. Sturgeon, S.R., Ronnenberg, A.G., Pomegranate and breast cancer: possible mechanisms of prevention. Nutr. Rev. 68 (2010), 122–128.
49. Syed, D.N., Chamcheu, J.-C., Adhami, V.M., Mukhtar, H., Pomegranate extracts and cancer prevention: molecular and cellular activities. Anti-cancer Agents Med. Chem., 13, 2013, 1149.
50. Tezcan, F., Gültekin-Özgüven, M., Diken, T., Özçelik, B., Erim, F.B., Antioxidant activity and total phenolic, organic acid and sugar content in commercial pomegranate juices. Food Chem. 115 (2009), 873–877.
51. Tracy, C.R., Henning, J.R., Newton, M.R., Aviram, M., Bridget Zimmerman, M., Oxidative stress and nephrolithiasis: a comparative pilot study evaluating the effect of pomegranate extract on stone risk factors and elevated oxidative stress levels of recurrent stone formers and controls. Urolithiasis 42 (2014), 401–408.
52. Viladomiu, M., Hontecillas, R., Lu, P., Bassaganya-Riera, J., Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents. Evidence-Based Complement. Altern. Med., 2013, 2013, 789764, 10.1155/2013/789764.
53. Wang, L., Ho, J., Glackin, C., Martins-Green, M., Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis. Transl. Oncol. 5 (2012), 344–355.
54. Wang, L., Martins-Green, M., Pomegranate and its components as alternative treatment for prostate cancer. Int. J. Mol. Sci. 15 (2014), 14949–14966.
55. Yoon, J.-H., Baek, S.J., Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med. J. 46 (2005), 585–596.